Antibodies to interferon (IFN) in hepatitis C patients relapsing while continuing recombinant IFN-α2 therapy

A number of trials have demonstrated that IFN-α is effective in chronic hepatitis C virus infection. It is known, however, that a number of chronic hepatitis C patients experience, after an initial response to IFN, disease reactivation or relapse (also called ‘breakthrough’) while IFN therapy is sti...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Prif Awduron: ANTONELLI, G, GIANNELLI, G, CURRENTI, M, SIMEONI, E, DEL VECCHIO, S, MAGGI, F, PISTELLO, M, ROFFI, L, PASTORE, G, CHEMELLO, L, DIANZANI, F
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: Blackwell Science Inc 1996
Pynciau:
Original Articles
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC2200453/
https://ncbi.nlm.nih.gov/pubmed/9099919
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1046/j.1365-2249.1996.43747.x
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg